Trafalis DT - Search Results

1

Preclinical evaluation of the homo-aza-steroid ester 13beta-hydroxy-13alpha-amino-13,17- seco-5alpha-androstan-17-oic-13,17-lactam-p-bis(2-chloroethyl)aminophenoxy acetate for the treatment of malignant melanoma.

Trafalis DT, Camoutsis C, Karamanakos P, Arvanitis A, Tegou E, Ziras N, Athanassiou AE. Trafalis DT, et al. J BUON. 2003 Oct-Dec;8(4):333-9. J BUON. 2003. PMID: 17472274

2

A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors.

Deligiorgi MV, Trafalis DT. Deligiorgi MV, et al. Among authors: trafalis dt. Int J Mol Sci. 2023 Apr 21;24(8):7630. doi: 10.3390/ijms24087630. Int J Mol Sci. 2023. PMID: 37108792 Free PMC article. Review.

3

Polyphenolics, glucosinolates and isothiocyanates profiling of aerial parts of Nasturtium officinale (Watercress).

Kyriakou S, Michailidou K, Amery T, Stewart K, Winyard PG, Trafalis DT, Franco R, Pappa A, Panayiotidis MI. Kyriakou S, et al. Among authors: trafalis dt. Front Plant Sci. 2022 Nov 15;13:998755. doi: 10.3389/fpls.2022.998755. eCollection 2022. Front Plant Sci. 2022. PMID: 36457522 Free PMC article.

4

Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises.

Anestopoulos I, Kyriakou S, Tragkola V, Paraskevaidis I, Tzika E, Mitsiogianni M, Deligiorgi MV, Petrakis G, Trafalis DT, Botaitis S, Giatromanolaki A, Koukourakis MI, Franco R, Pappa A, Panayiotidis MI. Anestopoulos I, et al. Among authors: trafalis dt. Pharmacol Ther. 2022 Dec;240:108301. doi: 10.1016/j.pharmthera.2022.108301. Epub 2022 Oct 23. Pharmacol Ther. 2022. PMID: 36283453 Review.

5

On the formation of steroidal amidoesters of 4-[N,N-bis(2-chloroethyl)amino]benzoic acid and their cytotoxic activity.

Camoutsis C, Sambani C, Trafalis DT, Peristeris P. Camoutsis C, et al. Among authors: trafalis dt. Eur J Med Chem. 1999 Jul-Aug;34(7-8):645-9. doi: 10.1016/s0223-5234(00)80033-1. Eur J Med Chem. 1999. PMID: 11278049

6

An overview on the antileukemic potential of D-homo-aza- and respective 17beta-acetamido-steroidal alkylating esters.

Camoutsis C, Trafalis DT. Camoutsis C, et al. Among authors: trafalis dt. Invest New Drugs. 2003 Feb;21(1):47-54. doi: 10.1023/a:1022964225715. Invest New Drugs. 2003. PMID: 12795529

7

Preclinical studies on NSC290205 aza-steroid alkylator activity in combination with adriamycin against lymphoid leukaemia.

Trafalis DT, Tsavdaridis D, Camoutsis C, Karayiani V, Mourelatos D, Dalezis P, Athanassiou A, Pangalis GA, Papageorgiou A. Trafalis DT, et al. Br J Haematol. 2005 Feb;128(3):343-50. doi: 10.1111/j.1365-2141.2004.05315.x. Br J Haematol. 2005. PMID: 15667536 Free article.

8

Research on the anti-tumour effect of steroid lactam alkylator (NSC-294859) in comparison with conventional chemotherapeutics in malignant melanoma.

Trafalis DT, Camoutsis C, Papageorgiou A. Trafalis DT, et al. Melanoma Res. 2005 Aug;15(4):273-81. doi: 10.1097/00008390-200508000-00007. Melanoma Res. 2005. PMID: 16034305

9

On the formation of 4-[N,N-bis(2-chloroethyl)amino]phenyl acetic acid esters of hecogenin and aza-homo-hecogenin and their antileukemic activity.

Camoutsis C, Trafalis D, Pairas G, Papageorgiou A. Camoutsis C, et al. Farmaco. 2005 Oct;60(10):826-9. doi: 10.1016/j.farmac.2005.07.006. Epub 2005 Aug 31. Farmaco. 2005. PMID: 16139280

10

Lactandrate: a D-homo-aza-androsterone alkylator in the treatment of breast cancer.

Trafalis DT, Geromichalos GD, Koukoulitsa C, Papageorgiou A, Karamanakos P, Camoutsis C. Trafalis DT, et al. Breast Cancer Res Treat. 2006 May;97(1):17-31. doi: 10.1007/s10549-005-9083-x. Epub 2005 Dec 1. Breast Cancer Res Treat. 2006. PMID: 16319980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters